Eye on the Expert: Eye on ctDNA – What Doctors Are Learning in Uveal Melanoma

Eye on the Expert: Eye on ctDNA – What Doctors Are Learning in Uveal Melanoma

In this Eye on the Expert webinar, leading experts discuss the growing role of circulating tumor DNA (ctDNA) in uveal melanoma and what this emerging technology may mean for patients and providers.

Joining the discussion are:

• Michael Krainock, Associate Medical Director of Oncology at Natera
• Dr. Kam Montazeri, Medical Oncologist
• Dr. Vincent Ma, Medical Oncologist

Together, they explore:

• What ctDNA is and how it is detected through blood testing
• What doctors are learning about ctDNA in uveal melanoma
• How ctDNA may be used to monitor disease and treatment response
• The potential benefits and limitations of this evolving technology
• Questions patients should ask when considering ctDNA testing

As research continues to advance, ctDNA is providing new insights into how cancer can be monitored and understood. This webinar offers an accessible overview of the science, current applications, and future possibilities for patients living with uveal melanoma.

Thank you to our sponsors for making this webinar possible:

• Ideaya Biosciences
• Delcath Systems
• Aura Biosciences
• Castle Biosciences
• Immunocore
• Natera

Rare Cancer. Resilient Hope. Revolutionary Research. 💙